North Macedonia vs Russian Federation: Share of E. coli infections resistant to cephalosporins
North Macedonia
60.0%
in 2022
Russian Federation
58.5%
in 2021
North Macedonia rank
11th
Russian Federation rank
13th
Share of E. coli infections resistant to cephalosporins over time
- North Macedonia
- Russian Federation
How they compare
North Macedonia currently reports 60.0% against 58.5% in Russian Federation, a difference of 1.5%.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Russian Federation ahead.
North Macedonia ranks 11th and Russian Federation ranks 13th of 46 countries.
North Macedonia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | North Macedonia | Russian Federation | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 71.5% | 66.0% | 5.5% | North Macedonia |
| 2020s | 68.5% | 65.8% | 2.6% | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, North Macedonia or Russian Federation?
- North Macedonia, at 60.0% against 58.5% in Russian Federation as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between North Macedonia and Russian Federation?
- 1.5%, with North Macedonia ahead.
- How many years of comparable data are there for North Macedonia and Russian Federation?
- 5 years are reported by both, from 2017 to 2021.
- How do North Macedonia and Russian Federation rank globally for share of e. coli infections resistant to cephalosporins?
- North Macedonia ranks 11th and Russian Federation ranks 13th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).